BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10390187)

  • 1. Defective expression of the SHP-1 phosphatase in polycythemia vera.
    Wickrema A; Chen F; Namin F; Yi T; Ahmad S; Uddin S; Chen YH; Feldman L; Stock W; Hoffman R; Platanias LC
    Exp Hematol; 1999 Jul; 27(7):1124-32. PubMed ID: 10390187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycythemia vera. V. Enhanced proliferation and phosphorylation due to vanadate are diminished in polycythemia vera erythroid progenitor cells: a possible defect of phosphatase activity in polycythemia vera.
    Dai CH; Krantz SB; Sawyer ST
    Blood; 1997 May; 89(10):3574-81. PubMed ID: 9160662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera.
    Asimakopoulos FA; Hinshelwood S; Gilbert JG; Delibrias CC; Göttgens B; Fearon DT; Green AR
    Oncogene; 1997 Mar; 14(10):1215-22. PubMed ID: 9121771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells.
    Xu MJ; Sui X; Zhao R; Dai C; Krantz SB; Zhao ZJ
    Blood; 2003 Dec; 102(13):4354-60. PubMed ID: 12920026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
    Yang W; Tabrizi M; Berrada K; Yi T
    Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression.
    Dai CH; Krantz SB; Green WF; Gilbert HS
    Br J Haematol; 1994 Jan; 86(1):12-21. PubMed ID: 7516694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of increased protein tyrosine phosphatase activity in polycythemia vera erythroid progenitor cells.
    Sui X; Krantz SB; Zhao Z
    Blood; 1997 Jul; 90(2):651-7. PubMed ID: 9226165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
    Dai C; Chung IJ; Krantz SB
    Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G turns off erythropoietin receptor signaling through JAK2 and JAK2 V617F dephosphorylation: clinical relevance in polycythemia vera.
    Menier C; Guillard C; Cassinat B; Carosella ED; Rouas-Freiss N
    Leukemia; 2008 Mar; 22(3):578-84. PubMed ID: 18059484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.
    Silva M; Richard C; Benito A; Sanz C; Olalla I; Fernández-Luna JL
    N Engl J Med; 1998 Feb; 338(9):564-71. PubMed ID: 9475763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis and polycythemia vera.
    Fernández-Luna JL
    Curr Opin Hematol; 1999 Mar; 6(2):94-9. PubMed ID: 10088639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JAK2 V617F stimulates proliferation of erythropoietin-dependent erythroid progenitors and delays their differentiation by activating Stat1 and other nonerythroid signaling pathways.
    Shi J; Yuan B; Hu W; Lodish H
    Exp Hematol; 2016 Nov; 44(11):1044-1058.e5. PubMed ID: 27473563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.
    Ugo V; Marzac C; Teyssandier I; Larbret F; Lécluse Y; Debili N; Vainchenker W; Casadevall N
    Exp Hematol; 2004 Feb; 32(2):179-87. PubMed ID: 15102479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells--signals emanating from the erythropoietin receptor.
    Klingmüller U
    Eur J Biochem; 1997 Nov; 249(3):637-47. PubMed ID: 9395308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythroblast transformation by the friend spleen focus-forming virus is associated with a block in erythropoietin-induced STAT1 phosphorylation and DNA binding and correlates with high expression of the hematopoietic phosphatase SHP-1.
    Nishigaki K; Hanson C; Ohashi T; Spadaccini A; Ruscetti S
    J Virol; 2006 Jun; 80(12):5678-85. PubMed ID: 16731906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-erythropoietin (EPO) receptor monoclonal antibodies distinguish EPO-dependent and EPO-independent erythroid progenitors in polycythemia vera.
    Fisher MJ; Prchal JF; Prchal JT; D'Andrea AD
    Blood; 1994 Sep; 84(6):1982-91. PubMed ID: 8081000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythaemia vera.
    Andersson P; LeBlanc K; Eriksson BA; Samuelsson J
    Eur J Haematol; 1997 Nov; 59(5):310-7. PubMed ID: 9414643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyn kinase plays important roles in erythroid expansion, maturation and erythropoietin receptor signalling by regulating inhibitory signalling pathways that control survival.
    Slavova-Azmanova NS; Kucera N; Louw A; Satiaputra J; Handoko A; Singer P; Stone L; McCarthy DJ; Klinken SP; Hibbs ML; Ingley E
    Biochem J; 2014 May; 459(3):455-66. PubMed ID: 24552351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.